The Walt Disney Company (NYSE: DIS) this week reported mixed results for the third quarter when its earnings declined despite modest revenue
Where’s Walt Disney Company (DIS) headed after mixed third quarter?
News
Categories
News
Ralph Lauren Corporation Q1 2024 Earnings Conference Call Insights
Key highlights from Ralph Lauren Corporation (RL) Q1 2024 Earnings Concall Management Update: [00:23:50] RL said China is one of its fastest-growing
What to expect when Home Depot (HD) reports Q2 2023 earnings
Shares of Home Depot Inc. (NYSE: HD) were up slightly on Thursday. The stock has gained 14% over the past three months.
Earnings: A snapshot of Generation Mining’s Q2 2023 financial results
Generation Mining Limited (TSX: GENM) has announced financial results for the second quarter of 2023, reporting a narrower net loss amid a
Earnings Summary: Ralph Lauren Corporation (RL) reports Q1 2024 results
Ralph Lauren Corporation (NYSE: RL), a leading provider of lifestyle products, on Thursday reported financial results for the first quarter of 2024.
Ocean Biomedical provides update on programs in malaria, fibrosis, and multiple cancers
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday provided an update on its broad range of programs in malaria, fibrosis, and multiple cancers.
Alibaba Group (BABA) Q1 2024 Earnings: Key financials and quarterly highlights
Alibaba Group Holding Limited (NYSE: BABA) reported first quarter 2024 earnings results today. Revenue totaled $32.2 billion, up 14% year-over-year. Net income
The Walt Disney Company Q3 2023 Earnings Conference Call Insights
Key highlights from The Walt Disney Company (DIS) Q3 2023 Earnings Concall Management Update: [00:04:59] DIS said it’s expanding its cruise fleet
Earnings Summary: Highlights of Illumina’s Q2 2023 results
Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023. Second-quarter revenue came in at
DIS Earnings: Walt Disney Company Q3 2023 revenue rises 4%
The Walt Disney Company (NYSE: DIS) announced third-quarter 2023 results on Wednesday, reporting an increase in revenues. The Burbank-headquartered entertainment behemoth said
Earnings Summary: Highlights of Organon’s Q2 2023 results
Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023. Second-quarter revenue came
Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights
Key highlights from Charles River Laboratories International, Inc (CRL) Q2 2023 Earnings Concall Q&A Highlights: [00:34:34] Sandy Draper with Guggenheim asked if
Four factors that do not work in favor of Beyond Meat (BYND)
Shares of Beyond Meat, Inc. (NASDAQ: BYND) stayed red on Wednesday. The stock has dropped 64% over the past 12 months. Earlier
Earnings Summary: Jacobs Solutions reports higher Q3 2023 revenues
Jacobs Solutions Inc. (NYSE: J), a leading provider of technical professional services, reported an increase in third-quarter revenues. The company also provided
Earnings Summary: A snapshot of Expeditors International’s Q2 results
Expeditors International of Washington, Inc. (NASDAQ: EXPD) announced financial results for the second quarter of 2023. The logistics company said it would
Walt Disney Q3 2023 Earnings Call: Listen Live and Get the Real-Time Transcript
Entertainment giant The Walt Disney Company (NYSE: DIS) will be reporting operating results for the third quarter of 2023 today after the
Earnings Summary: Charles River Laboratories reports Q2 2023 results
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023. For the
Trxade Health Inc. (NASDAQ: MEDS) Q2 2023 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that constantly innovates and expands into new verticals, with the latest such
Twilio (TWLO) Earnings: 2Q23 Key Numbers
Twilio (NYSE: TWLO) reported total revenue of $1.04 billion for the second quarter of 2023, which was up 10% year-over-year. Organic revenue
Ocean Biomedical’s share price target averages $18.21 amid continued progress in research programs
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday shared collective analyst research coverage from three firms, with current Buy recommendations and share price
Take-Two Interactive Software, Inc. Q1 2024 Earnings Conference Call Insights
Key highlights from Take-Two Interactive Software, Inc. (TTWO) Q1 2024 Earnings Concall Management Update: [00:16:53] On a management basis, TTWO’s operating expenses